{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/AKBA/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-15T19:03:13.244Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":3752,"canonical_name":"Akebia Therapeutics, Inc.","cik":"0001517022","uei":null,"lei":null,"duns":null,"ticker":"AKBA"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":19},"count":19,"timeline":[{"ts":"2026-10-14","kind":"sec.filing","form_type":"8-K","title":"8-K — Akebia Therapeutics, Inc. — 2026-10-14","url_slug":"/sec/cik-0001517022/8-k/0001517022-26-000071","accession_number":"0001517022-26-000071","importance":35},{"ts":"2026-08-10","kind":"sec.filing","form_type":"4","title":"4 — Akebia Therapeutics, Inc. — 2026-08-10","url_slug":"/sec/cik-0001517022/4/0001591467-26-000004","accession_number":"0001591467-26-000004","importance":30},{"ts":"2026-08-05","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Akebia Therapeutics, Inc. — 2026-08-05","url_slug":"/sec/cik-0001517022/10-q/0001517022-26-000051","accession_number":"0001517022-26-000051","importance":45},{"ts":"2026-08-05","kind":"sec.filing","form_type":"8-K","title":"8-K — Akebia Therapeutics, Inc. — 2026-08-05","url_slug":"/sec/cik-0001517022/8-k/0001517022-26-000050","accession_number":"0001517022-26-000050","importance":35},{"ts":"2026-08-05","kind":"sec.filing","form_type":"S-8","title":"S-8 — Akebia Therapeutics, Inc. — 2026-08-05","url_slug":"/sec/cik-0001517022/s-8/0001193125-26-335375","accession_number":"0001193125-26-335375","importance":30},{"ts":"2026-06-29","kind":"sec.form144","reporter":"Ostrowski Erik","title":"Officer","shares":56019,"usd_value":62220,"security_title":"Common Stock","approx_sale_date":"2026-06-29","accession_number":"0001517022-26-000044","importance":40.012444},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Ostrowski Erik","title":"SVP, CFO, CBO & Treasurer","shares":56019,"price_per_share":1.11,"usd_value":62181,"security_title":"Common Stock","importance":35.06218109},{"ts":"2026-06-22","kind":"sec.filing","form_type":"8-K","title":"8-K — Akebia Therapeutics, Inc. — 2026-06-22","url_slug":"/sec/cik-0001517022/8-k/0001517022-26-000043","accession_number":"0001517022-26-000043","importance":35},{"ts":"2026-06-22","kind":"sec.filing","form_type":"4","title":"4 — Akebia Therapeutics, Inc. — 2026-06-22","url_slug":"/sec/cik-0001517022/4/0001609480-26-000003","accession_number":"0001609480-26-000003","importance":30},{"ts":"2026-06-22","kind":"sec.filing","form_type":"4","title":"4 — Akebia Therapeutics, Inc. — 2026-06-22","url_slug":"/sec/cik-0001517022/4/0001808317-26-000001","accession_number":"0001808317-26-000001","importance":30},{"ts":"2026-06-22","kind":"sec.filing","form_type":"4","title":"4 — Akebia Therapeutics, Inc. — 2026-06-22","url_slug":"/sec/cik-0001517022/4/0001890219-26-000001","accession_number":"0001890219-26-000001","importance":30},{"ts":"2026-06-17","kind":"sec.insider.a","reporter":"ZUMWALT LEANNE M","title":"","shares":35700,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-17","kind":"sec.insider.a","reporter":"ROGERS MICHAEL W","title":"","shares":35700,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-17","kind":"sec.insider.a","reporter":"ADAMS ADRIAN","title":"","shares":35700,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-17","kind":"sec.insider.a","reporter":"Wolf Myles","title":"","shares":35700,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-17","kind":"sec.insider.a","reporter":"Smith Cynthia","title":"","shares":35700,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-17","kind":"sec.insider.a","reporter":"FRIESON RON","title":"","shares":35700,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-12","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Akebia Therapeutics, Inc. — 2026-05-12","url_slug":"/sec/cik-0001517022/schedule-13g/0000093751-26-000200","accession_number":"0000093751-26-000200","importance":55},{"ts":"2026-05-12","kind":"sec.13dg","reporter":"Akebia Therapeutics, Inc.","shares":11614006,"percent_of_class":4.3,"security_title":"SCHEDULE 13G","accession_number":"0000093751-26-000200","excerpt":null,"importance":55}]}